Published in Diabetes Obes Metab on November 22, 2011
Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity | NCT04642482
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet (2013) 2.66
A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes. Nature (2014) 2.29
The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol (2014) 2.13
Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ Health Perspect (2011) 1.80
Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol (2012) 1.69
Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays (2014) 1.64
Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS One (2015) 1.12
Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes (2013) 1.07
The devil lies in the details: how variations in polysaccharide fine-structure impact the physiology and evolution of gut microbes. J Mol Biol (2014) 1.07
Worms need microbes too: microbiota, health and aging in Caenorhabditis elegans. EMBO Mol Med (2013) 1.00
Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS One (2014) 1.00
Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol (2015) 0.96
Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol (2015) 0.95
Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. Ital J Pediatr (2012) 0.95
Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne) (2013) 0.90
Dual probiotic strains suppress high fructose-induced metabolic syndrome. World J Gastroenterol (2013) 0.88
Transcriptional analysis of prebiotic uptake and catabolism by Lactobacillus acidophilus NCFM. PLoS One (2012) 0.87
The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology. Psychosom Med (2015) 0.87
Gut microbes and host physiology: what happens when you host billions of guests? Front Endocrinol (Lausanne) (2014) 0.86
The nonfermentable dietary fiber hydroxypropyl methylcellulose modulates intestinal microbiota. FASEB J (2012) 0.85
The effect of the macrobiotic Ma-Pi 2 diet vs. the recommended diet in the management of type 2 diabetes: the randomized controlled MADIAB trial. Nutr Metab (Lond) (2014) 0.85
Method development for fecal lipidomics profiling. Anal Chem (2012) 0.85
Bugging inflammation: role of the gut microbiota. Clin Transl Immunology (2016) 0.84
Effects of probiotics in patients with diabetes mellitus type 2: study protocol for a randomized, double-blind, placebo-controlled trial. Trials (2013) 0.84
Pediatric non-alcoholic fatty liver disease: New insights and future directions. World J Hepatol (2014) 0.83
Obesity and irritable bowel syndrome: a comprehensive review. Gastroenterol Hepatol (N Y) (2014) 0.82
Broad scope method for creating humanized animal models for animal health and disease research through antibiotic treatment and human fecal transfer. Gut Microbes (2014) 0.81
An analysis of the role of the indigenous microbiota in cholesterol gallstone pathogenesis. PLoS One (2013) 0.81
Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes. Front Microbiol (2015) 0.80
Beyond traditional pharmacology: new tools and approaches. Br J Pharmacol (2015) 0.80
The gut microbiome as novel cardio-metabolic target: the time has come! Eur Heart J (2013) 0.79
Administration of defined microbiota is protective in a murine Salmonella infection model. Sci Rep (2015) 0.78
Increased Intake of Foods with High Nutrient Density Can Help to Break the Intergenerational Cycle of Malnutrition and Obesity. Nutrients (2015) 0.78
Are infants born by elective cesarean delivery without labor at risk for developing immune disorders later in life? Am J Obstet Gynecol (2012) 0.78
Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus. World J Gastroenterol (2014) 0.78
The Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes Mellitus. Front Endocrinol (Lausanne) (2016) 0.78
Effects of Synbiotics on Inflammatory Markers in Patients With Type 2 Diabetes Mellitus. Glob J Health Sci (2015) 0.77
Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis. Integr Med (Encinitas) (2015) 0.76
Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: A meta-analysis of randomized, controlled trials. Medicine (Baltimore) (2016) 0.75
The changing hypothesis of the gut. The intestinal microbiome is increasingly seen as vital to human health. EMBO Rep (2012) 0.75
Do colorectal cancer resections improve diabetes in long-term survivors? A case-control study. Surg Endosc (2013) 0.75
Regulation of life span by the gut microbiota in the short-lived African turquoise killifish. Elife (2017) 0.75
The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals. Front Nutr (2017) 0.75
Modulation of the gut microbiota by prebiotic fibres and bacteriocins. Microb Ecol Health Dis (2017) 0.75
Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol (1996) 7.12
Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell (1993) 4.76
Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet (1993) 4.55
Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria. Mol Microbiol (1997) 4.28
Improved site-directed mutagenesis method using PCR. Nucleic Acids Res (1991) 4.17
Molecular mechanisms of genetic adaptation to xenobiotic compounds. Microbiol Rev (1992) 4.14
High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut (2008) 4.10
[Fatal autointoxication with metformin]. Ned Tijdschr Geneeskd (2007) 3.70
Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J Biol Chem (1995) 3.46
Use of the Escherichia coli beta-glucuronidase (gusA) gene as a reporter gene for analyzing promoters in lactic acid bacteria. Appl Environ Microbiol (1994) 3.25
Functional analysis of promoters in the nisin gene cluster of Lactococcus lactis. J Bacteriol (1996) 3.23
Homology modelling and protein engineering strategy of subtilases, the family of subtilisin-like serine proteinases. Protein Eng (1991) 2.95
Identification and characterization of the lantibiotic nisin Z, a natural nisin variant. Eur J Biochem (1991) 2.93
Quantification of the contribution of various steps to the control of mitochondrial respiration. J Biol Chem (1982) 2.92
A maturation protein is essential for production of active forms of Lactococcus lactis SK11 serine proteinase located in or secreted from the cell envelope. J Bacteriol (1989) 2.89
Plasmid DNA in Streptococcus cremoris Wg2: Influence of pH on Selection in Chemostats of a Variant Lacking a Protease Plasmid. Appl Environ Microbiol (1982) 2.86
Molecular characterization of the plasmid-encoded eps gene cluster essential for exopolysaccharide biosynthesis in Lactococcus lactis. Mol Microbiol (1997) 2.68
[Melatonin: physiological and pathophysiological aspects and possible applications]. Ned Tijdschr Geneeskd (2006) 2.66
[The Montignac method: scientific foundation debatable]. Ned Tijdschr Geneeskd (1998) 2.65
Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene (1990) 2.58
Primary structure and organization of the gene for a procaryotic, cell envelope-located serine proteinase. J Biol Chem (1989) 2.50
Identification of mesophilic lactic acid bacteria by using polymerase chain reaction-amplified variable regions of 16S rRNA and specific DNA probes. Appl Environ Microbiol (1991) 2.44
Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med (2011) 2.39
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther (2007) 2.38
A molecular view of the intestinal ecosystem. Curr Issues Intest Microbiol (2000) 2.31
Controlled gene expression systems for lactic acid bacteria: transferable nisin-inducible expression cassettes for Lactococcus, Leuconostoc, and Lactobacillus spp. Appl Environ Microbiol (1997) 2.27
Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol (1994) 2.26
Gelatinase biosynthesis-activating pheromone: a peptide lactone that mediates a quorum sensing in Enterococcus faecalis. Mol Microbiol (2001) 2.22
Detection of Plasmid Transfer from Pseudomonas fluorescens to Indigenous Bacteria in Soil by Using Bacteriophage phiR2f for Donor Counterselection. Appl Environ Microbiol (1991) 2.14
Compatibility of insulin pens and cartridges. Lancet (1997) 2.13
Detection and localization of syntrophic propionate-oxidizing bacteria in granular sludge by in situ hybridization using 16S rRNA-based oligonucleotide probes. Appl Environ Microbiol (1996) 2.13
Evidence for the operation of a novel Embden-Meyerhof pathway that involves ADP-dependent kinases during sugar fermentation by Pyrococcus furiosus. J Biol Chem (1994) 2.13
Sequence analysis of the Pseudomonas sp. strain P51 tcb gene cluster, which encodes metabolism of chlorinated catechols: evidence for specialization of catechol 1,2-dioxygenases for chlorinated substrates. J Bacteriol (1991) 2.06
Cofactor engineering: a novel approach to metabolic engineering in Lactococcus lactis by controlled expression of NADH oxidase. J Bacteriol (1998) 2.05
Controlled overproduction of proteins by lactic acid bacteria. Trends Biotechnol (1997) 2.04
[Familial combined hyperlipidemia]. Ned Tijdschr Geneeskd (1996) 2.03
[Trial of pioglitazone for the secondary prevention of cardiovascular events in patients with diabetes mellitus type 2: insufficient evidence]. Ned Tijdschr Geneeskd (2006) 2.03
Demonstration of safety of probiotics -- a review. Int J Food Microbiol (1998) 2.02
Use of the lactococcal nisA promoter to regulate gene expression in gram-positive bacteria: comparison of induction level and promoter strength. Appl Environ Microbiol (1998) 1.96
Characterization of the Lactococcus lactis lactose operon promoter: contribution of flanking sequences and LacR repressor to promoter activity. J Bacteriol (1992) 1.91
Efficient random mutagenesis method with adjustable mutation frequency by use of PCR and dITP. Nucleic Acids Res (1993) 1.89
Comparison of lantibiotic gene clusters and encoded proteins. Antonie Van Leeuwenhoek (1996) 1.88
Plasmid transformation in Bacillus subtilis: fate of plasmid DNA. Mol Gen Genet (1981) 1.87
Cloning, nucleotide sequence, and regulatory analysis of the Lactococcus lactis dnaJ gene. J Bacteriol (1993) 1.84
Cloning and characterization of plasmid-encoded genes for the degradation of 1,2-dichloro-, 1,4-dichloro-, and 1,2,4-trichlorobenzene of Pseudomonas sp. strain P51. J Bacteriol (1991) 1.82
Influence of amino acid substitutions in the nisin leader peptide on biosynthesis and secretion of nisin by Lactococcus lactis. J Biol Chem (1994) 1.82
Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia (2007) 1.81
Transcriptional activation of the glycolytic las operon and catabolite repression of the gal operon in Lactococcus lactis are mediated by the catabolite control protein CcpA. Mol Microbiol (1998) 1.79
Purification and molecular characterization of ortho-chlorophenol reductive dehalogenase, a key enzyme of halorespiration in Desulfitobacterium dehalogenans. J Biol Chem (1999) 1.78
Molecular cloning, transcriptional analysis, and nucleotide sequence of lacR, a gene encoding the repressor of the lactose phosphotransferase system of Lactococcus lactis. J Biol Chem (1990) 1.75
Modern theories of metabolic control and their applications (review). Biosci Rep (1984) 1.75
Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology (1999) 1.74
Food-grade controlled lysis of Lactococcus lactis for accelerated cheese ripening. Nat Biotechnol (1997) 1.74
Food-grade cloning and expression system for Lactococcus lactis. Appl Environ Microbiol (1996) 1.74
The heterogeneity of rat-liver mitochondrial DNA. Biochim Biophys Acta (1978) 1.74
DNA isolation protocols affect the detection limit of PCR approaches of bacteria in samples from the human gastrointestinal tract. Syst Appl Microbiol (2001) 1.71
Control of gluconeogenesis in rat liver cells. Flux control coefficients of the enzymes in the gluconeogenic pathway in the absence and presence of glucagon. Biochem J (1986) 1.70
Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microbiol (1995) 1.68
The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia (2010) 1.67
In vivo nuclear magnetic resonance studies of glycolytic kinetics in Lactococcus lactis. Biotechnol Bioeng (1999) 1.67
Characterization of the Pseudomonas sp. strain P51 gene tcbR, a LysR-type transcriptional activator of the tcbCDEF chlorocatechol oxidative operon, and analysis of the regulatory region. J Bacteriol (1991) 1.66
Detection and characterization of lactose-utilizing Lactococcus spp. in natural ecosystems. Appl Environ Microbiol (1995) 1.64
Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology (1995) 1.61
Control of mitochondrial respiration. FEBS Lett (1983) 1.61
Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J Biol Chem (1992) 1.59
Structure, organization, and expression of the lct gene for lacticin 481, a novel lantibiotic produced by Lactococcus lactis. J Biol Chem (1993) 1.58
Purification and characterization of a novel ADP-dependent glucokinase from the hyperthermophilic archaeon Pyrococcus furiosus. J Biol Chem (1995) 1.57
Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles. J Hepatol (2001) 1.55
Protein engineering of lantibiotics. Antonie Van Leeuwenhoek (1996) 1.54
Characterization and overexpression of the Lactococcus lactis pepN gene and localization of its product, aminopeptidase N. Appl Environ Microbiol (1991) 1.54
Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev (2010) 1.53
Crystal structure of the Lrp-like transcriptional regulator from the archaeon Pyrococcus furiosus. EMBO J (2001) 1.53
Quality of life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections. Neth J Med (2004) 1.52
Functional analysis of the Lactococcus lactis galU and galE genes and their impact on sugar nucleotide and exopolysaccharide biosynthesis. Appl Environ Microbiol (2001) 1.52
Clogging of biliary endoprostheses: a new perspective. Gut (1990) 1.52
Molecular cloning, characterization, and nucleotide sequence of the tagatose 6-phosphate pathway gene cluster of the lactose operon of Lactococcus lactis. J Biol Chem (1991) 1.51
Metabolic engineering of Lactococcus lactis: influence of the overproduction of alpha-acetolactate synthase in strains deficient in lactate dehydrogenase as a function of culture conditions. Appl Environ Microbiol (1995) 1.51
Postprandial chylomicron formation and fat absorption in multidrug resistance gene 2 P-glycoprotein-deficient mice. Gastroenterology (2000) 1.50
Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol (2007) 1.48
A cell-free transcription system for the hyperthermophilic archaeon Pyrococcus furiosus. Nucleic Acids Res (1996) 1.47
Conversion of Lactococcus lactis from homolactic to homoalanine fermentation through metabolic engineering. Nat Biotechnol (1999) 1.46
Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl Environ Microbiol (1995) 1.45
Molecular and biochemical characterization of an endo-beta-1,3- glucanase of the hyperthermophilic archaeon Pyrococcus furiosus. J Biol Chem (1997) 1.45
APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required. Neth J Med (2012) 1.44
A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction. Endoscopy (1998) 1.44
[Diagnosis of vitamin B12 deficiency revised]. Ned Tijdschr Geneeskd (2005) 1.43
Functional analysis of glycosyltransferase genes from Lactococcus lactis and other gram-positive cocci: complementation, expression, and diversity. J Bacteriol (1999) 1.43
Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice. J Hepatol (2001) 1.43
Identification of a novel composite transposable element, Tn5280, carrying chlorobenzene dioxygenase genes of Pseudomonas sp. strain P51. J Bacteriol (1991) 1.42
Endothelial insulin receptor expression in human atherosclerotic plaques: linking micro- and macrovascular disease in diabetes? Atherosclerosis (2012) 1.41
[Iron-deficiency anaemia: a sign that requires an adequate explanation]. Ned Tijdschr Geneeskd (2007) 1.40
[The practice guideline 'Diabetes mellitus type 2' (second revision) from the Dutch College of General Practitioners; a response from the perspective of internal medicine]. Ned Tijdschr Geneeskd (2006) 1.40